183 related articles for article (PubMed ID: 19236731)
1. Utility of small-animal positron emission tomographic imaging of rats for preclinical development of drugs acting on the serotonin transporter.
Saijo T; Maeda J; Okauchi T; Maeda J; Morio Y; Kuwahara Y; Suzuki M; Goto N; Suzuki K; Higuchi M; Suhara T
Int J Neuropsychopharmacol; 2009 Sep; 12(8):1021-32. PubMed ID: 19236731
[TBL] [Abstract][Full Text] [Related]
2. Time course of in vivo 5-HTT transporter occupancy by fluvoxamine.
Takano A; Suhara T; Ichimiya T; Yasuno F; Suzuki K
J Clin Psychopharmacol; 2006 Apr; 26(2):188-91. PubMed ID: 16633150
[TBL] [Abstract][Full Text] [Related]
3. Presynaptic selectivity of a ligand for serotonin 1A receptors revealed by in vivo PET assays of rat brain.
Saijo T; Maeda J; Okauchi T; Maeda J; Morio Y; Kuwahara Y; Suzuki M; Goto N; Fukumura T; Suhara T; Higuchi M
PLoS One; 2012; 7(8):e42589. PubMed ID: 22880045
[TBL] [Abstract][Full Text] [Related]
4. Effect on [11C]DASB binding after tranylcypromine-induced increase in serotonin concentration: positron emission tomography studies in monkeys and rats.
Lundquist P; Roman M; Syvänen S; Hartvig P; Blomquist G; Hammarlund-Udenaes M; Långström B
Synapse; 2007 Jun; 61(6):440-9. PubMed ID: 17372973
[TBL] [Abstract][Full Text] [Related]
5. Occupancy of serotonin and norepinephrine transporter by milnacipran in patients with major depressive disorder: a positron emission tomography study with [(11)C]DASB and (S,S)-[(18)F]FMeNER-D(2).
Nogami T; Takano H; Arakawa R; Ichimiya T; Fujiwara H; Kimura Y; Kodaka F; Sasaki T; Takahata K; Suzuki M; Nagashima T; Mori T; Shimada H; Fukuda H; Sekine M; Tateno A; Takahashi H; Ito H; Okubo Y; Suhara T
Int J Neuropsychopharmacol; 2013 Jun; 16(5):937-43. PubMed ID: 23067569
[TBL] [Abstract][Full Text] [Related]
6. Occupancy of serotonin transporter by tramadol: a positron emission tomography study with [11C]DASB.
Ogawa K; Tateno A; Arakawa R; Sakayori T; Ikeda Y; Suzuki H; Okubo Y
Int J Neuropsychopharmacol; 2014 Jun; 17(6):845-50. PubMed ID: 24423243
[TBL] [Abstract][Full Text] [Related]
7. Acute occupancy of brain serotonin transporter by sertraline as measured by [11C]DASB and positron emission tomography.
Parsey RV; Kent JM; Oquendo MA; Richards MC; Pratap M; Cooper TB; Arango V; Mann JJ
Biol Psychiatry; 2006 May; 59(9):821-8. PubMed ID: 16213473
[TBL] [Abstract][Full Text] [Related]
8. Imaging the serotonin transporter during major depressive disorder and antidepressant treatment.
Meyer JH
J Psychiatry Neurosci; 2007 Mar; 32(2):86-102. PubMed ID: 17353938
[TBL] [Abstract][Full Text] [Related]
9. Proof of mechanism study of a novel serotonin transporter blocker, DA-8031, using [11C]DASB positron emission tomography and in vivo microdialysis.
Park HS; Jung IS; Lim NH; Sung JH; Lee S; Moon BS; Lee BC; Kang KK; Kim SE
Urology; 2014 Jul; 84(1):245.e1-7. PubMed ID: 24824409
[TBL] [Abstract][Full Text] [Related]
10. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.
Meyer JH; Houle S; Sagrati S; Carella A; Hussey DF; Ginovart N; Goulding V; Kennedy J; Wilson AA
Arch Gen Psychiatry; 2004 Dec; 61(12):1271-9. PubMed ID: 15583118
[TBL] [Abstract][Full Text] [Related]
11. Serotonin transporter occupancy of high-dose selective serotonin reuptake inhibitors during major depressive disorder measured with [11C]DASB positron emission tomography.
Voineskos AN; Wilson AA; Boovariwala A; Sagrati S; Houle S; Rusjan P; Sokolov S; Spencer EP; Ginovart N; Meyer JH
Psychopharmacology (Berl); 2007 Sep; 193(4):539-45. PubMed ID: 17497139
[TBL] [Abstract][Full Text] [Related]
12. High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography.
Suhara T; Takano A; Sudo Y; Ichimiya T; Inoue M; Yasuno F; Ikoma Y; Okubo Y
Arch Gen Psychiatry; 2003 Apr; 60(4):386-91. PubMed ID: 12695316
[TBL] [Abstract][Full Text] [Related]
13. Effects of increased endogenous serotonin on the in vivo binding of [11C]DASB to serotonin transporters in conscious monkey brain.
Yamamoto S; Onoe H; Tsukada H; Watanabe Y
Synapse; 2007 Sep; 61(9):724-31. PubMed ID: 17559093
[TBL] [Abstract][Full Text] [Related]
14. In Vivo Evaluation of 11C-DASB for Quantitative SERT Imaging in Rats and Mice.
Walker M; Ehrlichmann W; Stahlschmidt A; Pichler BJ; Fischer K
J Nucl Med; 2016 Jan; 57(1):115-21. PubMed ID: 26514178
[TBL] [Abstract][Full Text] [Related]
15. Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.
Laje G; Cannon DM; Allen AS; Klaver JM; Peck SA; Liu X; Manji HK; Drevets WC; McMahon FJ
Int J Neuropsychopharmacol; 2010 Jul; 13(6):715-24. PubMed ID: 20047709
[TBL] [Abstract][Full Text] [Related]
16. Effects of reduced endogenous 5-HT on the in vivo binding of the serotonin transporter radioligand 11C-DASB in healthy humans.
Talbot PS; Frankle WG; Hwang DR; Huang Y; Suckow RF; Slifstein M; Abi-Dargham A; Laruelle M
Synapse; 2005 Mar; 55(3):164-75. PubMed ID: 15605360
[TBL] [Abstract][Full Text] [Related]
17. PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method.
Kim JS; Ichise M; Sangare J; Innis RB
J Nucl Med; 2006 Feb; 47(2):208-14. PubMed ID: 16455625
[TBL] [Abstract][Full Text] [Related]
18. Mapping of serotonin transporters by positron emission tomography with [11C]DASB in conscious common marmosets: comparison with rhesus monkeys.
Yokoyama C; Yamanaka H; Onoe K; Kawasaki A; Nagata H; Shirakami K; Doi H; Onoe H
Synapse; 2010 Aug; 64(8):594-601. PubMed ID: 20340166
[TBL] [Abstract][Full Text] [Related]
19. Relationship between neuroticism personality trait and serotonin transporter binding.
Takano A; Arakawa R; Hayashi M; Takahashi H; Ito H; Suhara T
Biol Psychiatry; 2007 Sep; 62(6):588-92. PubMed ID: 17336939
[TBL] [Abstract][Full Text] [Related]
20. Potential of [11C]DASB for measuring endogenous serotonin with PET: binding studies.
Lundquist P; Wilking H; Höglund AU; Sandell J; Bergström M; Hartvig P; Långström B
Nucl Med Biol; 2005 Feb; 32(2):129-36. PubMed ID: 15721758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
